| 前收市價 | 67,900.00 |
| 開市 | 67,500.00 |
| 買盤 | 66,500.00 x 0 |
| 賣出價 | 66,600.00 x 0 |
| 今日波幅 | 66,500.00 - 67,700.00 |
| 52 週波幅 | 64,500.00 - 83,300.00 |
| 成交量 | |
| 平均成交量 | 12,811,598 |
| 市值 | 445.426T |
| Beta 值 (5 年，每月) | 0.92 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 2022年7月27日 - 2022年8月01日 |
| 遠期股息及收益率 | 1,444.00 (2.13%) |
| 除息日 | 2022年3月30日 |
| 1 年預測目標價 | 94,192.00 |
- Benzinga
Samsung Looks To Invest $356B Over Five Years in Next-Gen Technologies - Here's Why
Samsung Electronics Co, Ltd (OTC: SSNLF) looks to invest 450 trillion won ($356 billion) in the next five years to accelerate growth in semiconductors, biopharmaceuticals, and other next-generation technologies, Reuters reports. The investments through 2026 will likely help Samsung drive long-term growth in strategic areas like the chip sector while pledging aggressive investments in the biopharmaceutical sector. Samsung clarified that 80% of investments catered to South Korea, and the investmen
- South China Morning Post
Biden's Indo-Pacific Economic Framework unlikely to drive Japanese and South Korean businesses from China, analysts say
The US-led Indo-Pacific Economic Framework (IPEF) marks the latest attempt by Washington to counter China's rising influence in global supply chains, but strong incentives remain for businesses in South Korea and Japan to maintain ties with the huge Chinese market, according to analysts. The official launch of the IPEF during US President Joe Biden's first trip to Asia has triggered concerns in Beijing that the agreement - covering supply chains, digital trade, clean energy and anti-corruption e
- infocast
三星電子:未來5年斥2.8萬億港元投資晶片及製藥等業務
南韓三星電子公布,將在未來5年投資450萬億韓圜(約2.79萬億港元),以加速在半導體、生物製藥和其他下一代技術領域的增長,預計將創造107萬個工作崗位。三星表示,這些持續到2026年的投資預計將幫助三星在晶片等戰略領域長期增長,同時承諾在生物製藥領域積極投資。三星在公告中沒有將電動汽車電池作為未來的增長引擎,但強調確保國內晶片和生物供應鏈將具有戰略意義,對南韓的經濟安全很重要。投資額中的80%將在南韓進行。是次公告並包括去年8月做出的240萬億韓圜的投資承諾。該集團的電池部門三星 SDI 和佳士拿母公司 Stellantis 定於周二宣布他們在美國印第安納州的新電池工廠。 (BC)#三星電子 #晶片 #製藥 #美股
